Targeted, intermittent booster tDCS: a novel add-on application for maintenance treatment in a schizophrenia patient with refractory auditory verbal hallucinations

Asian J Psychiatr. 2014 Oct:11:79-80. doi: 10.1016/j.ajp.2014.05.012. Epub 2014 Jun 4.

Authors

Venkataram Shivakumar¹, Janardhanan C Narayanaswamy¹, Sri Mahavir Agarwal¹, Anushree Bose¹, Aditi Subramaniam¹, Ganesan Venkatasubramanian²

Affiliations

¹ The Schizophrenia Clinic, Department of Psychiatry & Translational Psychiatry Laboratory, Neurobiology Research Centre, National Institute of Mental Health and Neurosciences, Bangalore, India.
² The Schizophrenia Clinic, Department of Psychiatry & Translational Psychiatry Laboratory, Neurobiology Research Centre, National Institute of Mental Health and Neurosciences, Bangalore, India. Electronic address: venkat.nimhans@yahoo.com.

PMID: 25453706
DOI: 10.1016/j.ajp.2014.05.012

No abstract available

Publication types

Case Reports
Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Antipsychotic Agents / therapeutic use
Combined Modality Therapy / methods
Female
Hallucinations / complications
Hallucinations / drug therapy
Hallucinations / therapy*
Humans
Schizophrenia / complications
Schizophrenia / drug therapy
Schizophrenia / therapy*
Schizophrenic Psychology
Transcranial Direct Current Stimulation / methods*
Treatment Outcome

Substances

Antipsychotic Agents

Grants and funding

Wellcome Trust/United Kingdom